ADPT
Adaptive Biotechnologies Corp
26.50$
+1.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -123.1% | -58.8% | -91.6% | -40.1% | -58.3% | -26.3% | -54.3% | -21.1% | -7.6% | 2.9% | -13.5% | -8.9% | -6.8% | |
| 20.1% | 11.8% | 12.5% | 11.6% | 9.9% | 9.4% | 9.0% | 7.6% | 4.7% | 5.9% | 5.4% | 5.2% | 5.2% | |
| 40.4% | 34.0% | 34.1% | 30.0% | 29.1% | 27.0% | 23.2% | 22.7% | 14.1% | 17.7% | 16.8% | 15.5% | 15.9% | |
| -49.2% | -7.7% | -24.6% | 6.5% | -28.1% | 6.4% | -30.8% | -9.0% | -36.0% | -3.4% | -8.9% | 1.4% | -13.5% | |
| 7.3% | 2.8% | 3.6% | 4.0% | 0.7% | 0.2% | 2.4% | 1.1% | 0.4% | 0.9% | 1.1% | 1.7% | 1.0% | |
| 68.9% | 7.0% | 106.3% | 13.6% | 11.4% | 46.6% | 48.8% | 5.7% | 18.4% | -11.5% | 12.9% | -60.8% | -8.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -34.9% | – | |
| 0.0% | 0.2% | 0.1% | 0.1% | 0.1% | 0.3% | 10.4% | 2.7% | 1.8% | 30.2% | 10.6% | 198.7% | 56.2% | |
| -54.1% | -51.7% | 14.7% | -26.4% | -46.8% | 20.6% | 5.2% | -12.7% | 12.6% | 21.6% | 10.0% | 129.0% | 41.1% | |
| -130.4% | -61.7% | -95.2% | -44.1% | -59.0% | -26.5% | -56.7% | -22.2% | -8.0% | 2.0% | -14.6% | -10.6% | -7.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.